CAN HISTORICAL CONTROLS BE USED IN CURRENT CLINICAL-TRIALS IN OSTEO-SARCOMA - ANALYSIS OF PROGNOSTIC FACTORS

被引：12

作者：

BROSTROM, LA

APARISI, T

INGIMARSSON, S

LAGERGREN, C

NILSONNE, U

STRANDER, H

SODERBERG, G

机构：

[1] KAROLINSKA HOSP, RADIUM HEMMET, DEPT DIAGNOST RADIOL, S-10401 STOCKHOLM, SWEDEN

[2] KAROLINSKA HOSP, DEPT TUMOR PATHOL, S-10401 STOCKHOLM, SWEDEN

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1980年 / 6卷 / 12期

关键词：

D O I：

10.1016/0360-3016(80)90257-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1711 / 1715

页数：5

共 32 条

[1] BRODERS AC, 1939, SURG GYNECOL OBSTET, V69, P267
[2] CADE S, 1955, J R Coll Surg Edinb, V1, P79
[3] AMPUTATION AND ADRIAMYCIN IN PRIMARY OSTEOSARCOMA
CORTES, EP
HOLLAND, JF
WANG, JJ
SINKS, LF
BLOM, J
SENN, H
BANK, A
GLIDEWELL, O
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) : 998 - 1000
[4] DAHLIN D, 1973, BONE TUMORS GENERAL, P156
[5] Dahlin D.C., 1975, CLIN ORTHOP RELAT R, V111, P23
[6] FARR GH, 1974, CANCER-AM CANCER SOC, V34, P1150, DOI 10.1002/1097-0142(197410)34:4<1150::AID-CNCR2820340426>3.0.CO
[7] 2-S
[8] FRIEDMAN M A, 1972, Journal of Surgical Oncology, V4, P482, DOI 10.1002/jso.2930040512
[9] CURRENT THERAPIES IN OSTEOSARCOMA
HANDELSMAN, H
CARTER, SK
[J]. CANCER TREATMENT REVIEWS, 1975, 2 (01) : 77 - 83
[10] ADJUVANT METHOTREXATE AND CITROVORUM-FACTOR TREATMENT OF OSTEOGENIC SARCOMA
JAFFE, N
FREI, E
TRAGGIS, D
BISHOP, Y
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) : 994 - 997